Weiss & Lurie, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of HealthSpring, Inc. (NYSE: HS) arising from its proposed acquisition by Cigna Corporation (NYSE: CI) for $55.00 per share in cash, in a transaction valued at approximately $3.8 billion. The transaction is expected to close in the first half of 2012. Weiss & Lurie is investigating whether HealthSpring’s Board acted in the best interests of its shareholders in approving the transaction and whether HealthSpring shareholders are receiving adequate consideration for their shares. HealthSpring’s existing management team, led by its Chairman and Chief Executive Officer, Herbert A. Fritch, will lead Cigna’s expansion into its Seniors and Medicare segments after the transaction closes. If you own HealthSpring shares and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Michael A. Rogovin either by email at email@example.com or by telephone at (888) 593-4771. Weiss & Lurie has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded institutions and individuals and obtained important corporate governance in these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or the improper dissemination of materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at firstname.lastname@example.org or fill out the form on our website, http://www.weisslurie.com/contact/report_fraud/.Attorney Advertising. Past results do not guarantee a similar outcome.